Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07374419
What this trial is testing

Atamparib in Patients With Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaSolid Tumor
Nerviano Medical Sciences (Shanghai) Ltd. 178
Early research (Phase 1)Active Not RecruitingNCT02321501
What this trial is testing

Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer

Who this might be right for
ALK PositiveLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm+3 more
M.D. Anderson Cancer Center 37
Early research (Phase 1)Study completedNCT05396300
What this trial is testing

A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerSolid CancersGastric Cancer
Weijia Fang, MD 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390839
What this trial is testing

Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH - Subprotocol Z1C)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+1 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT05490771
What this trial is testing

Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm+3 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)UnknownNCT05986981
What this trial is testing

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers

Who this might be right for
Solid Tumor, Adult
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06090266
What this trial is testing

OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Who this might be right for
CancerTumor, SolidMalignant Neoplasm+4 more
OncoResponse, Inc. 168
Early research (Phase 1)UnknownNCT06394622
What this trial is testing

A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors

Who this might be right for
Solid Tumor
Fudan University 12
Not applicableActive Not RecruitingNCT04090619
What this trial is testing

Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers

Who this might be right for
Advanced Malignant Solid NeoplasmCaregiverMetastatic Malignant Solid Neoplasm+4 more
M.D. Anderson Cancer Center 192
Early research (Phase 1)Ended earlyNCT04241835
What this trial is testing

Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function

Who this might be right for
Hepatic ImpairmentAdvanced Malignant Solid Tumor
Epizyme, Inc. 18
Early research (Phase 1)Study completedNCT02575781
What this trial is testing

SAR428926 in Patients With Advanced Solid Tumors

Who this might be right for
Neoplasm Malignant
Sanofi 34
Early research (Phase 1)Looking for participantsNCT06716619
What this trial is testing

A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors

Who this might be right for
Tumor Associated Lymph Node T CellAdvanced Solid TumorImmunotherapy+1 more
Guangzhou FineImmune Biotechnology Co., LTD. 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT06357975
What this trial is testing

Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Genetic Changes (MATCH - Subprotocol C1)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 44
Early research (Phase 1)UnknownNCT06154343
What this trial is testing

GQ1005 in Subjects With HER2-Expressing Advanced Solid Tumors

Who this might be right for
HER2 Expressing or Mutated Advanced Malignant Solid Tumors
GeneQuantum Healthcare (Suzhou) Co., Ltd. 150
Early research (Phase 1)Active Not RecruitingNCT03872947
What this trial is testing

TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorColorectal CancerCholangiocarcinoma+9 more
Toray Industries, Inc 138
Testing effectiveness (Phase 2)Looking for participantsNCT04165590
What this trial is testing

Plasmodium Immunotherapy for Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
CAS Lamvac Biotech Co., Ltd. 60
Early research (Phase 1)Study completedNCT00675350
What this trial is testing

Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors

Who this might be right for
Hematologic Tumors
ChemGenex Pharmaceuticals 12
Early research (Phase 1)UnknownNCT05344976
What this trial is testing

MSLN STAR-T Cells in the Treatment of Advanced Malignant Solid Tumors

Peking University 12
Early research (Phase 1)Study completedNCT00836888
What this trial is testing

ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan

Who this might be right for
Malignant Solid Tumor
Ono Pharmaceutical Co., Ltd. 17
Testing effectiveness (Phase 2)Study completedNCT06208124
What this trial is testing

IMM-6-415 in RAS/RAF Mutant Solid Tumors

Who this might be right for
Advanced Solid Tumor (Phase 1)Pancreas AdenocarcinomaNon-small Cell Lung Cancer+1 more
Immuneering Corporation 30
Next Page